Back to search
FDAFDA · Food and drugs·Recall number D-1211-2018

Fenofibrate Tablets, USP 145 mg, 90-count bottles, Rx only, Manufactured for: Camber Pharmaceuticals, Inc. Piscataway, NJ, 08854, NDC 31722-596-90

Published October 3, 2018 · Recall initiated: September 12, 2018

Summary

FDA records drug Class III recall D-1211-2018, published October 3, 2018 and initiated September 12, 2018. Recalling firm: Hetero Labs, Ltd. - Unit III; Status: Terminated; Reported quantity: 5,424 bottles; Lot: Lot #: E181370, Exp. 5/2020. Class III means the product is not likely to cause adverse health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Presence of Foreign Tablet/Capsule: A foreign identified as Valacyclovir tablet 500 mg was co-mingled in a bottle containing Fenofibrate Tablets, USP 145 mg.

What to do

Voluntary: Firm initiated · Letter

Get an email if FENOFIBRATE has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
FENOFIBRATE
Manufacturer
Hetero Labs, Ltd. - Unit III
Distributor
Indiana and Louisiana
UPC
0331722596305
Lot
Lot #: E181370, Exp. 5/2020
Risk classification
Class III
Area (FDA)
drug
Country
India

Related recalls

Questions about this recall

Was Fenofibrate Tablets, USP 145 mg, 90-count bottles, Rx only, Manufactured for: Camber Pharmaceuticals, Inc. Piscataway, NJ, 08854, NDC 31722-596-90 recalled?

Yes. FDA published recall D-1211-2018 on October 3, 2018. Reported hazard: Presence of Foreign Tablet/Capsule: A foreign identified as Valacyclovir tablet 500 mg was co-mingled in a bottle containing Fenofibrate Tablets, USP 145 mg.

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: FENOFIBRATE. UPC: 0331722596305.